CIK 0001609809
- Non-accelerated filer
- Smaller reporting company
Seres Therapeutics, Inc.
Sign in to watch- Ticker
- MCRB
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 274326290
- Phone
- +1 617-945-9626
- Business address
- 200 SIDNEY STREET, CAMBRIDGE, MA, 02139
- Former names
- Seres Therapeutics, Inc., Seres Health, Inc.
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4/A Open-market sale Chief Technology Officer & EVP sold 18,640 shares at $31.94 ($595,362)
- 4 Open-market sale Chief Technology Officer & EVP sold 9,390 shares at $10.87 ($102,069)
- 4 Open-market sale Chief Technology Officer & EVP sold 9,250 shares at $35.00 ($323,750)
- 4 Open-market sale Chief Medical Officer and EVP sold 4,156 shares at $35.18 ($146,207)
- 4 Open-market sale President and CEO sold 20,000 shares at $35.00 ($700,000)
- 4 Open-market sale Chief Medical Officer and EVP sold 38,064 shares at $35.14 ($1,337,512)
- 4 Open-market sale Chief Technology Officer & EVP sold 9,390 shares at $34.18 ($320,950)
- 4 Open-market sale President and CEO sold 88,211 shares at an average $29.45 ($2,597,474)
- 4 Open-market sale President and CEO sold 56,789 shares at an average $29.81 ($1,692,705)
- 4 Open-market sale CFO and EVP sold 4,533 shares at $29.54 ($133,905)
- 4 Open-market sale Chief Technology Officer & EVP sold 9,390 shares at $27.23 ($255,690)
- 4 Open-market sale CFO and EVP sold 5,001 shares at an average $28.28 ($141,445)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
Page 16 of 19 · 380 filings